Skip to research
Margin Monkey THEMARGINMONKEY Start my free trialTry free

Solventum (SOLV) stock in plain English

Free brief · no signupStart here
SOLVPublished Nov 13, 2026
Solventum Corp
Healthcare · Medical Instruments & Supplies
Sells advanced wound care dressings, dental restoratives, hospital filtration hardware, and medical billing software.
Assets:
Four core segmentsMedSurg, Dental Solutions, Health Information Systems, and Purification
Over 20 manufacturing sitesFacilities across North America, Europe, and Asia produce specialized medical supplies
Around 22,000 employeesStaff spread across international sales, clinical training, engineering, and manufacturing
Locked assetIn the full report
Rated Nov 19, 2026

Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.

46
OPS ScoreOperating finances
Latest quote
-0.79%$85.80
$14.56B
96.1×
$8.18B

Change shown by the quote provider. Data may be delayed.

Financial statements, in plain wordsSales, profit, debt and cash, year by year
Published Nov 13, 2026Quotes updated Nov 20, 04:10 UTCOPS Score, TMM Score and the rating are research summaries, not advice or forecasts.
That was SOLV. The desk has 1,900+ more companies.Each one comes with its scores, its flags and the sources behind them.
7 days free · No card

What does Solventum (SOLV) do?

Solventum Corp (SOLV) is a U.S.-listed company in Healthcare (Medical Instruments & Supplies). What it does: Sells advanced wound care dressings, dental restoratives, hospital filtration hardware, and medical billing software. Spun out from 3M, it manufactures specialized hospital wound dressings, dental composites, and clinical coding software. It is worth $14.56B on the market and sold $8.18B over the last year.

Market cap
$14.56B
P/E ratio
96.1×
Annual sales
$8.18B
Sector
Healthcare
Industry
Medical Instruments & Supplies
Brief updated
Nov 13, 2026

Brands and businesses behind SOLV

  • Tegaderm: Transparent film and wound dressings sold to hospitals to secure intravenous lines and protect healing skin.
  • Filtek: Dental restorative materials sold to dental clinics for filling cavities and repairing tooth structures.
  • Cavilon: Barrier films and skin protectants sold to healthcare providers to prevent tissue breakdown from moisture.
  • RelyX: Dental cements sold to dental practitioners to bond crowns, bridges, and orthodontic appliances.

SOLV’s flags, in plain English

Each flag is a number from Solventum’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 13, 2026.

Wide Gross Margin

Gross margin of 55.5% after the cost of making its products. There is a large gap between what its products cost to make and what they sell for, and that gap pays for everything else.

Insiders Hold

Insiders own 15.3% of the company. The people who run the company own a meaningful slice of it, so they gain or lose along with other shareholders.

Earnings Jumping

Profits up 18.6% this year. Profit per share is growing fast this year. One year does not make a trend, so check whether sales grew too.

Priced for Perfection

Priced at 96.1 times its yearly profit, so a lot of growth is already expected. The share price already assumes strong results, so news that is merely good can still send it down.

1 more green flag and 1 more risk note open with the free trial. Try it free for 7 days.

Questions about SOLV

How big is Solventum?

Solventum’s market cap is $14.56B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $8.18B: what customers paid the company over the last year, before any costs.

What is SOLV’s P/E ratio?

SOLV’s P/E ratio is 96.1×. Investors pay about 96.1 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.

What could go wrong with SOLV?

The company carries over eight billion dollars in total debt resulting from its separation from 3M. That is one risk on Solventum’s card. Its first risk flag is Priced for Perfection, explained above. The card holds 1 more risk note for trial accounts. A flag reads what the company reported. It does not predict the price.

Where do these numbers come from?

From Solventum’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. SOLV’s filings on SEC.gov. The Margin Monkey is research, not advice.

Your first 7 days are free.Search all 1,900+ companies and open every card. Members also get the ratings, Picks and the TMM Score.
7 days free · No card